Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 16-week, randomised, double-blind, placebo-controlled, single-centre study to investigate fluid retention in insulin-treated subjects with type 2 diabetes mellitus and varying degrees of autonomic neuropathy when administered rosiglitazone 4mg twice daily
rosiglitazone
49653/376
NCT00422955
Neuropathy, Diabetic
Phase 3
 
September 2013

Powered by ideaPoint, Inc.